Tendon & Sports Injuries stem cell therapy — your questions answered (2026)

About stem cell therapy for Tendon & Sports Injuries

Tendons transmit muscle force to bone and can develop acute tears or chronic degenerative tendinopathy. Healing and symptoms vary by tendon, load, vascularity, injury severity and rehabilitation. Mesenchymal stromal cells (MSCs), extracellular vesicles and other biological approaches are being studied for proposed effects on inflammation, vascular signalling and collagen organisation observed mainly in preclinical models. These mechanisms have not established stronger tendon tissue or faster safe return to sport in people. The registry table on this page lists relevant studies and their current recruitment status.

The evidence for Tendon & Sports Injuries

Human tendon studies of cell and exosome approaches vary by tendon, acute or chronic injury, product, comparator, rehabilitation and outcome measure. Case-series return-to-activity rates cannot distinguish treatment effects from natural healing, selection or concurrent physiotherapy. Structural imaging changes do not automatically establish pain relief or safe return to sport. No pooled response rate is published here because the studies are too heterogeneous for a single figure to be meaningful. The registered studies and their own prespecified endpoints are listed in the registry table on this page.

Private investigational tendon cell or exosome procedures can involve separate charges for image guidance, imaging, repeat administration, rehabilitation, travel and treatment of complications. Prices do not indicate regulatory approval, tendon healing or faster return to sport. Patients should request an itemised written quote and verify sponsor, insurer and patient responsibilities. Evidence-based diagnosis, load management and rehabilitation must not be delayed.

Do stem cells heal tendons?

Cell therapy for Tendon & Sports Injuries may be offered as an individualised programme, but regulatory status depends on the product, processing, indication and jurisdiction. It is currently investigational. Verify authorisation status, cell source, release testing and clinical evidence for the specific proposal.

One injection or several?

Schedules vary by the exact product, protocol, route, monitoring needs and clinical context. Request the proposed schedule and its evidence before making travel arrangements.

Return-to-sport timeline?

Eligibility depends on the protocol's inclusion and exclusion criteria and an appropriately qualified clinician's assessment. An online checklist cannot determine candidacy or replace medical advice.

EU cost?

The partner-published indicative range for an Tendon & Sports Injuries programme is €3,000–€8,000 for treatment. Request a current written quotation and compare product, dose, visits, inclusions and follow-up before using country ranges as a benchmark.

Sources & further reading

We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.

• Open clinical trials for Tendon & Sports Injuries (ClinicalTrials.gov) ↗
• Peer-reviewed research on PubMed ↗
• ISSCR patient guide — what to ask ↗
• FDA consumer warning on stem-cell therapies ↗
• EMA — advanced-therapy (ATMP) framework ↗

← Back to Tendon & Sports Injuries overview · Tendon & Sports Injuries cost →